HELPING THE OTHERS REALIZE THE ADVANTAGES OF MODAFINIL NORGE

No precise dose adjustment advised when tofacitinib coadministered with potent CYP2C19 inhibitors; decrease tofacitinib dose if coadministered with both of those average CYP3A4 and strong CYP2C19 inhibitors .Prevent or substitute A different drug for these prescription drugs when feasible. Examine for loss of therapeutic outcome if medication have